RBC Capital Markets described the subsequent decline in Lillys stock as an overreaction, noting that the overall safety profile remains favorable and emphasizing that one liver case does not make a signal. 1 Similarly, Evercore ISI analysts cautioned against overinterpretation, writing that we cannot look at this single liver case in a silo, particularly given that hepatic events have been reported across the GLP-1 class and may reflect confounding factors
PLEASE SEE OUR TERMS REGARDING YOUR RIGHTS IN ANY DISPUTE INVOLVING OUR SERVICES, INCLUDING A MANDATORY ARBITRATION CLAUSE, AND A WAIVER TO A JURY TRIAL OR CLASS ACTION, THAT LIMITS YOUR RELIEF
Learn more about Tirzepatide Weight Loss in Florida Semaglutide may be reviewed as part of a medical weight loss plan for eligible adults
| 2004 Jul 23;18(11):1549-60
Talk to your provider before making changes
Ueda P, Sderling J, Wintzell V, Svanstrm H, Pazzagli L, Eliasson B, et al